Nearly 50 new cancer therapies are approved every year. This is good news. "But for patients and their treating physicians, ...
Existing investors Battery Ventures, Left Lane Capital, and M-Fund also joined to fuel Fetcherr's global growth and ...
The Parallel-R1 framework uses reinforcement learning to teach models how to explore multiple reasoning paths at once, ...
EchoNet-Measurements shows promise against sonographers and in an external validation set but needs prospective study.
Why Western economies must unleash armies of entrepreneurs and digitize SMEs to build Godzilla-sized enterprises for the global age.
The award-winning science writer Peter Brannen makes the case for an often vilified compound in “The Story of CO2 Is the Story of Everything.” By Jaime Green Jaime Green is the author of “The ...
(HealthDay News) — Machine learning and deep learning models applied to integrated clinical and claims data can improve prediction of chronic kidney disease (CKD) progression to end-stage renal ...
Chinese AI developer DeepSeek said it spent $294,000 on training its R1 model, much lower than figures reported for U.S.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback